A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (Q6076490)

From MaRDI portal
Revision as of 18:59, 26 April 2024 by Importer (talk | contribs) (‎Created a new Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)





scientific article; zbMATH DE number 7750872
Language Label Description Also known as
English
A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes
scientific article; zbMATH DE number 7750872

    Statements

    A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes (English)
    0 references
    0 references
    17 October 2023
    0 references
    adaptive design
    0 references
    competing risk
    0 references
    late-onset
    0 references
    phase I/II clinical trial
    0 references
    targeted therapy
    0 references

    Identifiers